The 12 closest competitors and alternatives to Exobiosphere among biotech companies — ranked by similarity to what Exobiosphere actually does, not by market-cap band.
Subscribe to see Exobiosphere’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Exobiosphere is a privately held space-biotech company headquartered in Esch-sur-Alzette, Luxembourg. Founded in 2024, its mission is to extend and improve life on Earth and in space by utilizing microgravity as a new dimension for biology to accelerate drug research.
Exobiosphere is a biotech company headquartered in Luxembourg. It has raised at least $3.1M across the 2 funding rounds on record. Its most recent funding round, Grant, raised $1.1M in August 2026. Xcout tracks 3 named people at Exobiosphere, including Kyle Acierno (CEO).
At least $3.1M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $1.1M | — | |
| Seed | $2M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Exobiosphere by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Space Biotechnology
Space LiinTech is a space biopharma company headquartered in Daejeon, South Korea, that develops AI-enabled microgravity platforms for pharmaceutical research.
Biotechnology
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Biotechnology
Exa Biosciences builds infrastructure solutions designed to power the development of next-generation therapeutic biologics. The company provides foundational support and technologies tailored for organizations and researchers working in the biotherapeutic sector.
Life Sciences
ASTRA Therapeutics is a biotechnology and drug design company focused on animal health and anti-parasitic drug discovery. Located at the Swiss Innovation Park Innovaare in Villigen, Switzerland, the company leverages atomic resolution to craft next-generation small-molecule treatments against parasitic diseases.
Biotechnology
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Biotechnology
Starpax Biopharma Inc. is a Canadian biotechnology research and development company incorporated in 2017 to commercialize cancer-treatment technology licensed from Polytechnique Montréal. The company has developed a platform technology utilizing magnetodrones designed to treat solid tumors while aiming to preserve organ function and avoid traditional side effects.
Similar biotech company
Aspect Biosystems develops bioengineered cellular medicines and implantable tissue therapeutics using a proprietary bioprinting platform that integrates AI, computational design, and advanced biomaterials. The company serves the biotechnology and pharmaceutical industries by creating treatments to replace, repair, or supplement biological functions for metabolic and endocrine diseases.
Similar biotech company
Graph Therapeutics is a next-generation techbio company headquartered in Vienna, Austria. The company is involved in developing advanced therapeutic solutions.
Similar biotech company
Just-Evotec Biologics is a Seattle-based subsidiary of Evotec SE focused on innovative biologics drug discovery and manufacturing. Operating research and production facilities such as J.POD in Washington State, the company develops technologies for global access to biotherapeutics. It partners with major philanthropic organizations like the Gates Foundation to advance global health.
Biotechnology
Engine Biosciences is a Singapore-based biotechnology company and venture-creation platform that combines machine learning, computational biology, and laboratory experimentation to discover and develop new medicines. It builds and invests in therapeutic-focused biotech companies, serving pharmaceutical and healthcare markets.
Similar biotech company
Axiom Bio is a biotechnology company that develops AI-driven predictive models and translational intelligence tools to assess drug toxicity and minimize clinical trial failures in drug discovery.
Biotechnology
ChemoSensoryX Biosciences SA is a biotechnology company that provides discovery products and services related to chemical communications mediated by human olfactory and taste receptors. Utilizing a proprietary technology platform and screening facilities, the company develops solutions for odor and taste management, including malodor blockers, pleasant odor enhancers, and applications for flavors, fragrances, and drug discovery.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Exobiosphereand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →